Log in to save to my catalogue

111 In-Bevacizumab Imaging of Renal Cell Cancer and Evaluation of Neoadjuvant Treatment with the Vas...

111 In-Bevacizumab Imaging of Renal Cell Cancer and Evaluation of Neoadjuvant Treatment with the Vas...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_2967_jnumed_110_078030

111 In-Bevacizumab Imaging of Renal Cell Cancer and Evaluation of Neoadjuvant Treatment with the Vascular Endothelial Growth Factor Receptor Inhibitor Sorafenib

About this item

Full title

111 In-Bevacizumab Imaging of Renal Cell Cancer and Evaluation of Neoadjuvant Treatment with the Vascular Endothelial Growth Factor Receptor Inhibitor Sorafenib

Journal title

Journal of Nuclear Medicine, 2010-11, Vol.51 (11), p.1707-1715

Language

English

Formats

More information

Alternative Titles

Full title

111 In-Bevacizumab Imaging of Renal Cell Cancer and Evaluation of Neoadjuvant Treatment with the Vascular Endothelial Growth Factor Receptor Inhibitor Sorafenib

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_citationtrail_10_2967_jnumed_110_078030

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_2967_jnumed_110_078030

Other Identifiers

ISSN

0161-5505

E-ISSN

2159-662X

DOI

10.2967/jnumed.110.078030

How to access this item